BBP-671

N/A

Report date: 2024/12/16 15:29:53
NME

Base Information

Drug NameBBP-671
Drug Alias NameBBP-671
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPantothenate kinase activators
TargetsPantothenate kinase
Therapy Area/IndicationsMethylmalonic acidaemiaOrganic acidemiaPropionic Acidemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoa Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMethylmalonic acidaemiaOrganic acidemiaPropionic Acidemia

Other Information

ATC CodeN/A
Related LinksN/A